ZAP-70 tyrosine kinase is required for LFA-1-dependent T cell migration

被引:62
|
作者
Soede, RDM [1 ]
Wijnands, YM [1 ]
Van Kouteren-Cobzaru, I [1 ]
Roos, E [1 ]
机构
[1] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands
来源
JOURNAL OF CELL BIOLOGY | 1998年 / 142卷 / 05期
关键词
integrin; activation; chemotaxis; SDF-1; metastasis;
D O I
10.1083/jcb.142.5.1371
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ZAP-70 tyrosine kinase is essential for T cell activation by the T cell receptor. We show that ZAP-70 is also required for migration of T cells that is dependent on the integrin LFA-1. Invasion of TAM2D2 T cell hybridoma cells into fibroblast monolayers, which is LFA-1-dependent, was blocked by overexpression of dominant-negative ZAP-70 and by piceatannol but not by herbimycin A. The Syk inhibitor piceatannol blocks the Syk homologue ZAP-70, which is expressed by TAM2D2 cells, with the same dose dependence as the inhibition of invasion. Dominant-negative ZAP-70 completely inhibited the extensive metastasis formation of TAM2D2 cells to multiple organs Key words: upon i.v. injection into mice. Migration of TAM2D2 metastasis cells through filters coated with the LFA-1 ligand ICAM-1, induced by 1 ng/ml of the chemokine SDF-1, was blocked by anti-LFA-1 mAb and also abrogated by dominant-negative ZAP-70 and piceatannol. In contrast, migration induced by 100 ng/ml SDF-1 was independent of both LFA-I and ZAP-70. LFA-1 cross-linking induced tyrosine phosphorylation, which was blocked by dominant-negative ZAP-70 and piceatannol. We conclude that LFA-1 engagement triggers ZAP-70 activity that is essential for LFA-1-dependent migration.
引用
收藏
页码:1371 / 1379
页数:9
相关论文
共 50 条
  • [21] T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase
    Magnan, A
    Di Bartolo, V
    Mura, AM
    Boyer, C
    Richelme, M
    Lin, YL
    Roure, A
    Gillet, A
    Arrieumerlou, C
    Acuto, O
    Malissen, B
    Malissen, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04): : 491 - 505
  • [22] Nonpeptidic SH2 inhibitors of the tyrosine kinase ZAP-70
    Vu, CB
    Corpuz, EG
    Pradeepan, SG
    Violette, S
    Bartlett, C
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (20) : 3009 - 3014
  • [23] Structure of the human ZAP-70 protein tyrosine kinase gene.
    Elder, ME
    Wang, FL
    Lin, D
    PEDIATRIC RESEARCH, 1996, 39 (04) : 45 - 45
  • [24] Tyrosine 315 determines optimal recruitment of ZAP-70 to the T cell antigen receptor
    Di Bartolo, V
    Malissen, M
    Dufour, E
    Sechet, E
    Malissen, B
    Acuto, O
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (02) : 568 - 575
  • [25] A MODEL AT HEREDITARY IMMUNODEFICIENCY DUE TO ZAP-70 TYROSINE KINASE DEFECT
    HIVROZ, C
    LEDEIST, F
    FISCHER, A
    M S-MEDECINE SCIENCES, 1995, 11 (02): : 268 - 272
  • [26] Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration.
    Ticchioni, M
    Charvet, C
    Noraz, N
    Lamy, L
    Steinberg, M
    Bernard, A
    Deckert, M
    FASEB JOURNAL, 2002, 16 (05): : A1210 - A1210
  • [27] Hypermorphic heterozygous variants in the tyrosine kinase ZAP-70 underlie autoimmune disease
    van der Made, Caspar I.
    Smeets, Ruben L.
    Potjewijd, Judith
    Simons, Annet
    Vorsteveld, Emil E.
    Schuurs-Hoeijmakers, Janneke H. M.
    De Munnik, Sonja A.
    Vreeburg, Maaike
    Koenen, Hans J. P. M.
    Netea, Mihai G.
    van Well, Gijs T. J.
    van de Veerdonk, Frank L.
    Hoischen, Alexander
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 73 - 73
  • [28] CHROMOSOMAL LOCATION OF THE SYK AND ZAP-70 TYROSINE KINASE GENES IN MICE AND HUMANS
    KU, G
    MALISSEN, B
    MATTEI, MG
    IMMUNOGENETICS, 1994, 40 (04) : 300 - 302
  • [29] A MUTATION IN ZAP-70 PROTEIN-TYROSINE KINASE RESULTS IN A SELECTIVE IMMUNODEFICIENCY
    ROIFMAN, CM
    JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (06) : S52 - S62
  • [30] SEVERE COMBINED IMMUNODEFICIENCY DUE TO MUTATIONS IN THE GENE OF ZAP-70 TYROSINE KINASE
    LOTTEAU, V
    M S-MEDECINE SCIENCES, 1994, 10 (10): : 1038 - 1039